| 发明名称 | Combination of a prostaglandin receptor agonist and an MC1R receptor agonist for the treatment and/or prevention of pigmentation disorders | ||
| 摘要 | A combination of compounds is described for the treatment and/or prevention of skin conditions linked to hypopigmentation. Also described, is a combination product that includes at least one prostaglandin receptor agonist and at least one MC1R receptor agonist, as a medicament for use simultaneously, separately or spread out over time for the treatment and/or prevention of skin conditions linked to hypopigmentation, such as vitiligo. | ||
| 申请公布号 | US9364455(B2) | 申请公布日期 | 2016.06.14 |
| 申请号 | US201214365851 | 申请日期 | 2012.12.17 |
| 申请人 | GALDERMA RESEARCH & DEVELOPMENT | 发明人 | Martel Philippe;Suzuki Itaru;Voegel Johannes;Andres Philippe;Rethore Sandrine |
| 分类号 | A61K38/34;C07K14/68;A61K31/216;A61K45/06;A61K31/165;A61K31/192;A61K31/4178;A61K31/454;A61K38/33;A61K38/35 | 主分类号 | A61K38/34 |
| 代理机构 | Dentons US LLP | 代理人 | Dentons US LLP |
| 主权项 | 1. A combination product comprising at least one prostaglandin receptor agonist and at least one MC1R receptor agonist, as a medicament for use simultaneously, separately or spread out over time for the treatment of dermatological conditions linked to hypopigmentation, wherein the prostaglandin receptor agonist is present at a concentration of between approximately 0.001% and 1% by weight, relative to the total weight of a composition comprising the prostaglandin receptor agonist, and the MC1R receptor agonist is present at a concentration of between approximately 0.001% and 10% by weight, relative to the total weight of a composition comprising the MC1R receptor agonist. | ||
| 地址 | Biot FR | ||